MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation by Chen, Peter et al.
MMP7 Shedding of Syndecan-1 Facilitates Re-
Epithelialization by Affecting a2b1 Integrin Activation
Peter Chen*, Laura E. Abacherli, Samuel T. Nadler, Ying Wang, Qinglang Li, William C. Parks
Center for Lung Biology, Department of Medicine, University of Washington, Seattle, Washington, United States of America
Abstract
Background: Lung injury promotes the expression of matrix metalloproteinase-7 (MMP7, matrilysin), which is required for
neutrophil recruitment and re-epithelialization. MMP7 governs the lung inflammatory response through the shedding of
syndecan-1. Because inflammation and repair are related events, we evaluated the role of syndecan-1 shedding in lung re-
epithelialization.
Methodology/Principal Finding: Epithelial injury induced syndecan-1 shedding from wild-type epithelium but not from
Mmp7
2/2 mice in vitro and in vivo. Moreover, cell migration and wound closure was enhanced by MMP7 shedding of
syndecan-1. Additionally, we found that syndecan-1 augmented cell adhesion to collagen by controlling the affinity state of
the a2b1 integrin.
Conclusion/Significance: MMP7 shedding of syndecan-1 facilitates wound closure by causing the a2b1 integrin to assume a
less active conformation thereby removing restrictions to migration. MMP7 acts in the lungs to regulate inflammation and
repair, and our data now show that both these functions are controlled through the shedding of syndecan-1.
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Introduction
Being contiguous with the environment, mucosal surfaces are
constantly exposed to toxic and pathogenic insults [1,2]. As a first
line of defense, mucosal epithelia have evolved to quickly respond
to various forms of injury by coordinating the inflammatory
response while repairing wounded tissue. MMP7 (matrilysin), a
member of the matrix metalloproteinase (MMP) family, is
expressed by all mucosal surfaces and is quickly upregulated in
response to epithelial injury [3–11]. Accordingly, MMP7 functions
to facilitate repair and regulate the acute inflammatory response
[3–7].
The lungs are lined by a prototypical mucosal epithelium. Like
other mucosal surfaces, injured lungs quickly initiate a pre-
programmed response to recruit inflammatory cells and repair the
damaged tissue. The roles of MMP7 in regulating repair and
inflammation are particularly prominent in the lungs. In fact, the
lung phenotypes are so pronounced that re-epithelialization and
neutrophil recruitment into the alveolar space are almost
completely abrogated in MMP7-deficient mice [3–6]. Our group
previously reported that E-cadherin is shed in vivo from the injured
lung epithelium by MMP7 [5]. Although we then proposed that E-
cadherin shedding could promote repair by reorganizing cell-cell
contacts, newer studies indicate that MMP7 shedding of E-
cadherin functions in adaptive immune responses later in the
response to injury (McGuire et al., unpublished observations).
Early in the injury response, MMP7 promotes inflammation by
shedding syndecan-1/KC (CXCL8) complexes that permit the
transepithelial movement of neutrophils [4]. As shedding of
syndecan-1 occurs coincident with the onset of re-epithelialization,
we hypothesized that proteolysis of this membrane factor may also
function in repair.
Syndecan-1 is one of four members of a family of transmem-
brane heparan sulfate proteoglycans with distinct expression
patterns and functions [12]. Epithelial cells primarily express
syndecan-1, and observations from various models indicate that it
participates in wound healing [4,13–17]. For example, suppression
of syndecan-1 expression in epithelial cells induces a pro-migratory
phenotype [18,19], suggesting that intact syndecan-1 may
moderate re-epithelialization. Consistent with this idea, synde-
can-1 surface levels are decreased in injured cornea and skin
during active repair [20,21], and increased levels of syndecan-1
ectodomain are present in dermal wound fluid [22–24]. Syndecan-
1 shedding from the cell surface is a MMP-dependent process in
vitro and in vivo, and MMP shedding of syndecan-1 induces cell
migration [25]. Moreover, MMP7 has been identified as the
syndecan-1 sheddase in lung mucosa [4,25–29].
Because it can modulate repair, we tested the idea that shedding
of syndecan-1 from injured lung epithelium functions to promote
re-epithelialization. Using in vitro and in vivo models, we found that
syndecan-1 is shed from repairing epithelial cells after injury.
Additionally, MMP7 shedding of syndecan-1 enhances cell
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6565migration and wound closure. Our data further demonstrates that
syndecan-1 restrains cell migration by modifying the activation
state of the a2b1 integrin. Our results establish that MMP7
shedding of syndecan-1 facilitates lung re-epithelialization and acts
as a unified mechanism that regulates both acute inflammation
and repair.
Results
MMP7 is required for cell migration
Air-liquid interface (ALI) cultures of airway epithelial cells
differentiate into a complete mucociliary epithelium and act
phenotypically similar to the in vivo epithelium thus providing a
relevant organotypic culture system to study the airway mucosal
epithelium [6]. We wounded wild-type (WT) and MMP7-null
(Mmp7
2/2) ALI cultures and observed the wound closure with
time-lapse microscopy (Video S1). Whereas injured WT epithe-
lium covered the wound in the field of view within 24 h, Mmp7
2/2
cells had a dramatic inability to close the wound. Wounded
epithelium responds to injury by initially spreading over the
wound followed by cell proliferation and migration over the
damaged areas [30,31]. Time-lapse microscopy revealed that the
Mmp7
2/2 epithelium appeared to retain the ability to spread over
the wound, as these cells formed extended lamellipodial fronts
soon after wounding. However, only WT epithelium continued to
migrate and complete the wound healing process. These data
confirm that MMP7 is required for re-epithelialization.
MMP7 shedding of syndecan-1 in repair
Because MMP7 sheds syndecan-1 from lung epithelium in
response to injury [4], we evaluated if release of this proteoglycan
functions in re-epithelialization. Immunofluorescence signal for
syndecan-1 was decreased at the wound front of WT ALI cultures
but remained in Mmp7
2/2 epithelium after injury (Figure 1A).
Cells distal to the wound, representing uninjured epithelium, had
equivalent syndecan-1 signal between WT and Mmp7
2/2 cultures.
We also evaluated re-epithelialization in vivo using the naphthalene
injury model. Naphthalene specifically kills Clara cells, which
make up about 60% of airway epithelium in mice, while sparing
other epithelial cell types and with minimal inflammation [6,32].
In a well-described pattern of repair, the remaining epithelium
becomes squamated and migrates to cover the denuded areas left
by the sloughed Clara cells. By 14 days post-injury, the epithelium
is repaired, and the Clara cell population is fully restored. Using
this model, we observed syndecan-1 signal persisted in the
Mmp7
2/2 epithelium after injury but was diminished in WT
airway epithelium (Figure 1B). Vehicle-injected WT and
Mmp7
2/2 mice had similar levels of syndecan-1 signal in an
expected basolateral distribution (data not shown). Moreover, shed
syndecan-1 was detected in the medium of injured WT cultures
and in bronchoalveolar lavage fluid from naphthalene injured WT
mice but not in Mmp7
2/2 samples (Figure 1C). These in vitro and in
vivo findings confirm that MMP7 sheds syndecan-1 from injured
lung epithelial cells.
MMP7 releases syndecan-1 restrictions on wound closure
The observations that migration and syndecan-1 shedding were
diminished in Mmp7
2/2 tissue and cells after injury suggested that
release of syndecan-1 is needed to promote re-epithelialization. To
study this idea, we injured syndecan-1 null (Sdc1
2/2) ALI cultures,
which grew and differentiated indistinguishable from WT cultures,
and found wounds closed significantly faster than in WT cultures
Figure 1. Syndecan-1 shedding from injured lung epithelium. (A) ALI cultures 24 h after wounding and (B) lungs two days after naphthalene
injury were processed for syndecan-1 immunostaining (scale bar=100 mm). ALI culture sections were counterstained with Dapi (blue). The white
dashed line and the white arrows demarcate the wound front in ALI cultures and naphthalene-injured airway epithelium, respectively. Images are
representative of consistent findings in several replicates (n$3 ALI cultures or mice). (C) Syndecan-1 dot blot was performed using the 281-2
antibody (1:1000) as previously described [4] on conditioned medium (CM) from injured ALI cultures and from bronchoalveolar lavage (BAL) fluid
collected from lungs four days after naphthalene injury. Two independent samples were blotted from each genotype, but the leftmost WT BAL
sample did not completely flow.
doi:10.1371/journal.pone.0006565.g001
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epithelialization in vivo was quantitatively faster in Sdc1
2/2 mice
with cuboidal cells appearing sooner compared to WT airways, in
which the lining remained patchy and squamated at this time
(Figure 2B). To quantify repair in vivo, we immunostained for
Clara-cell specific protein (CCSP) and found the number of
CCSP-positive cells along the airways was 2.5 times greater in
Sdc1
2/2 mice at 4 days post-naphthalene compared to WT mice
(Figure 2C). The airway epithelium in WT and Sdc1
2/2 mice was
equivalent in vehicle-injected controls and had similar degrees of
injury after naphthalene injury (data not shown). The accelerated
wound closure in Sdc1
2/2 cultures and airways indicate that
MMP7 shedding of syndecan-1 releases restrictions to epithelial
cell movement.
To understand better the mechanisms by which syndecan-1
restrains repair, we used a retroviral vector to create BEAS-2b cells
(immortalized human bronchial airway epithelial cell line) that
stably expressed shRNA that complements either human synde-
can-1 mRNA (B2b
shRNA.Sdc1) or a nonsense (luciferase) mRNA
(B2b
shRNA.luc). Syndecan-1 expression was markedly knocked
down in B2b
shRNA.Sdc1 cells but not altered in B2b
shRNA.luc cells,
which had the expected basolateral distribution of the proteogly-
can (Figure 3A). Cell monolayers were injured and revealed
significantly faster wound closure in B2b
shRNA.Sdc1 compared to
B2b
shRNA.luc cells (Figure 3B). These findings recapitulated the
more efficient re-epithelialization phenotype in Sdc1
2/2 ALI and
naphthalene injury models and further support our conclusion that
intact syndecan-1 functions to restrain migration.
Because MMP7 was undetectable by western blot in condi-
tioned medium from BEAS-2b cells (data not shown), faster
migration seen with targeted ablation of syndecan-1 suggest that
release of this surface proteoglycan–and not other potential
substrates–is the MMP7-mediated mechanism that promotes re-
epithelialization. We stably overexpressed active MMP7 in
B2b
shRNA.Sdc1 cells and transiently transfected these cells with
constructs that express either wild-type mouse syndecan-1
(mSdc1), which would not be affected by the shRNA targeting
the human transcript, or a mutant mouse syndecan-1 resistant to
MMP7 proteolysis (NC-mSdc1). Cells expressing NC-mSdc1 had
reduced rates of wound closure compared to cells expressing
cleavable WT syndecan-1 (Figure 3C). To assess the role of
syndecan-1 in cell migration directly, we used a phagokinetic
colloid gold migration assay [33] to measure the movement of
individual cells over 24 h (Figure 4A). Consistent with rapid repair
seen in Sdc1
2/2 ALI cultures and tissue, cells that lack syndecan-1
(B2b
shRNA.Sdc1) migrated faster than control cells (B2b
shRNA.luc)
(Figure 4A). Together, these findings indicate that MMP7 cleavage
of syndecan-1 releases restrictions to migration.
Syndecan-1 affects cell adhesion and spreading
The ability of a cell to adhere and spread over a matrix
substratum is essential for migration. Although they migrated
faster, cell spreading was significantly blunted in B2b
shRNA.Sdc1
cells compared to B2b
shRNA.luc cells (13.3%62.9 versus
49.8%67.7, respectively; p,0.005; Figure 4B). Furthermore,
B2b
shRNA.Sdc1 cells were two-fold less adherent to type I collagen
Figure 2. Syndecan-1 restrains lung re-epithelialization. (A) Wild-type and Sdc1
2/2 ALI cultures were wounded, and the repair was quantified.
Each experiment was performed in triplicate and repeated at least 6 times. Original magnification6100. *p,0.0005 by Student’s T-Test. (B) Wild-type
and Sdc1
2/2 mice 4 days after naphthalene injury were processed for (B) H&E staining and (C) CCSP immunostaining (scale bar=100 mm). Each
panel is from a different mouse and has an accompanying enlarged portion of the airway (i.e., airways from 3 different mice were shown). In H&E
stained sections, Sdc1
2/2 airway epithelium was more cuboidal in appearance. In contrast, wild-type epithelium was predominantly squamous with
persistently exposed substratum (arrows). Additionally, the number of CCSP+cells per linear length of basement membrane (BM) along the airways
(asterisk) was determined to quantify the epithelial repair after naphthalene injury. n=4 mice, *p,0.01 by Student’s T-Test.
doi:10.1371/journal.pone.0006565.g002
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shRNA.luc cells after 30 min of contact (p,0.0001;
Figure 4C). However, knock-down of syndecan-1 did not
completely ablate the ability to ligate collagen and only changed
the kinetics of adhesion as both B2b
shRNA.Sdc1 and B2b
shRNA.luc
cell were attached to the substratum by 4 h (data not shown).
Syndecan-1 regulates a2b1 integrin affinity
Our findings consistently showed syndecan-1-dependent effects
on collagen matrices indicating that this proteoglycan affects
specific cell-matrix interactions to modulate its effect on cell
migration. Syndecan-1 can associate with certain integrins [34],
and we evaluated the b1 integrin subunit as it is common to all the
fibrillar collagen binding integrins [35]. Deficiency of syndecan-1
did not affect the overall levels of b1 integrins (Figure 4D).
However, the b1 integrin subunit can assume active and inactive
conformations conferring dramatic differences in substrate affinity
[36]. Using a conformation-specific antibody, we found active b1
present on the basolateral surface of B2b
shRNA.luc cells but largely
absent in B2b
shRNA.Sdc1 cells lacking syndecan-1 (Figure 4D).
Because a2b1 is the primary collagen binding integrin in most
epithelia including the lungs [37], these data suggest that
syndecan-1 governs the activation state of this receptor.
We tested the effects of syndecan-1 on the a2b1 integrin with cell
adhesion assays in the presence of functional activating and
inhibiting antibodies (Figure 4E). In the presence of isotype
antibody, we again showed differential binding of B2b
shRNA.luc and
B2b
shRNA.Sdc1 cells to collagen (100% vs 50.568.4%, respectively).
Blocking antibodies against the b1 integrin subunit or specific to
the a2b1 integrin abrogated binding of both B2b
shRNA.luc and
B2b
shRNA.Sdc1 cell adhesion to collagen (b1: 9.362.5% vs.
9.763.0%, respectively; a2b1: 24.4612.0% vs. 7.963.1%,
respectively). In contrast, whereas addition of a b1 activating
Figure 3. MMP7 shedding of syndecan-1 releases restrictions to migration. BEAS-2b cells were used to create stable knockdown cell lines
using shRNA targeting either the luciferase gene as a control (B2b
shRNA.luc) or syndecan-1 (B2b
shRNA.Sdc1). Monolayers of B2b
shRNA.luc and B2b
shRNA.Sdc1
cells were (A) immunostained for syndecan-1 (green; scale bar=100 mm), and (B) scratched and wound closure was quantified. n=4, p,0.0001 by
Student’s T-Test. (C) Wound closure was determined for B2b
shRNA.Sdc1 cells stably overexpressing MMP7 and transiently transfected with no plasmid
(Mock), mouse syndecan-1 (mSdc1) or a MMP7-resistant syndecan-1 mutant (NC-Sdc1). The graph is a representative figure of reproducible results on
Type I collagen.
doi:10.1371/journal.pone.0006565.g003
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shRNA.luc and B2b
shRNA.Sdc1 cells were used in a gold colloid migration assay
(scale bar=100 mm). Total migration area was measured for cells plated on type I collagen. n=4, *p,0.05 by Student’s T-Test. (B) The percent of
spread cells versus all cells was measured after plating on type I collagen. n=5, *p,0.005 by Student’s T-Test. (C) The relative adhesion percent for
cells on type I collagen was determined. n=6, *p,0.0005 by Student’s T-Test. (D) Monolayers of B2b
shRNA.luc and B2b
shRNA.Sdc1 cells were
immunostained for the b1 integrin subunit (red) using all (clone AIIB2) or active conformation-specific (clone 12G10) antibodies. Immunofluorescent
images counterstained with Dapi (scale bar=100 mm). (E) The relative adhesion percent for cells on type I collagen was measured in the presence of
control, b1 subunit inhibiting antibody (clone AIIB2; 1 mg/ml), b1 subunit activating antibody (clone HUTS-21; 10 mg/ml) and/or a2b1 integrin
inhibiting antibody (clone BHA2.1, 20 mg/ml). Isotype control antibodies were matched to specific antibody experiment. n$3, *p,0.05, **p,0.01,
***p,0.001 by 2-way ANOVA and Bonferroni analysis.
doi:10.1371/journal.pone.0006565.g004
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shRNA.luc adhesion to
collagen (87.0615.7%), it did augment adhesion of syndecan-1-
deficient B2b
shRNA.Sdc1 cells compared to isotype control
(87.9611.0% vs. 50.568.4%, respectively). Forced b1 integrin
subunit activation did not rescue cell adhesion in the presence of
an a2b1 integrin inhibitor for either B2b
shRNA.luc or B2b
shRNA.Sdc1
cells (30.9615.5% vs. 17.5610.5%, respectively). These data
indicate that syndecan-1 modulates cell adhesion to collagen via
the a2b1 integrin and suggests that this regulation occurs by
controlling the affinity state of the integrin.
Modulation of the a2b1 integrin during re-
epithelialization
Because the presence of syndecan-1 appears to shift the a2b1
integrin to a higher affinity state, MMP7 shedding of syndecan-1
may release this control and deactivate the integrin to a lower
affinity, thereby allowing more relaxed cell-matrix interactions
that are permissive to cell migration. Indeed, whereas some degree
of cell adhesion is needed to generate migratory traction, excessive
adhesion impedes cell movement [38,39]. In consideration of these
concepts, our model would predict that in the presence of
syndecan-1, the a2b1 integrin restrains cell migration during re-
epithelialization. If true, forced activation of the b1 integrin
subunit should slow re-epithelialization seen in Sdc1
2/2 ALI
cultures. Moreover, inhibiting a2b1 integrin ligation should
overcome the diminished migration seen in Mmp7
2/2 conditions
where syndecan-1 persists at the cell surface.
To test these ideas, we first established that blocking the a2b1
integrin enhances wound repair in ALI airway epithelial cultures.
Wounded WT ALI cultures had enhanced wound closure in the
presence of either an a2 subunit inhibiting antibody or an a2b1
inhibiting peptide (Figure 5 and 6). In contrast, Sdc1
2/2 ALI
cultures had no additional augmentation of wound closure
suggesting the a2b1 integrin contributed minimally to cell
migration in the absence of syndecan-1 (Figure 5). However,
and consistent with our hypothesis, the a2 subunit and a2b1
integrin inhibitors both increased the wound closure rate of
injured Mmp7
2/2 ALI cultures (Figure 6). These data support our
idea that in the presence of syndecan-1, the higher affinity state of
the a2b1 integrin restrains migration of the repairing airway
epithelium.
Next, we wounded WT and Sdc1
2/2 ALI cultures in the
presence of control, b1-activating, or b1-inhibiting antibodies
(Figure 7). Inhibition of b1 integrins augmented wound closure
Figure 5. Wounded Sdc1
2/2 lung epithelium is unaffected bya2b1 integrin inhibition. Wild-type and Sdc1
2/2 ALI cultures were injured in
the presence of a control (hamster isotype IgG2;1 0mg/ml), a2 integrin subunit inhibiting antibody (clone Ha1/29; 10 mg/ml) or a2b1 integrin
inhibiting peptide (5 mM). The percent wound closure was determined 24 h after injury. *p,0.05 by 2-way ANOVA and Bonferroni analysis. n=4;
Original magnification6100.
doi:10.1371/journal.pone.0006565.g005
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2/2
cultures. Conversely, forced activation of the b1 integrin subunit
slowed the wound closure rate of injured Sdc1
2/2 ALI cultures to
that of WT conditions. Congruous with our hypothesis, inhibiting
b1 integrin subunit restored wound closure rate of Mmp7
2/2
cultures to WT levels (Figure 8). In WT ALI cultures, the
activating b1 integrin antibody significantly slowed wound closure
relative to control conditions, but this effect was seen at the higher
concentration used (compare Figures 7 and 8). In contrast, the
higher concentration of b1 integrin activating antibody had no
effect on Mmp7
2/2 wound closure rate suggesting that the b1
integrin subunit was already maximally activated.
Discussion
Injury opens avenues for pathogenic entry across a breached
barrier. Therefore, the body has evolved mechanisms to recruit
inflammatory cells to combat potential pathogens while quickly
repairing the damaged tissue. The lungs, in particular, have
adapted its mucosal surface to utilize MMP7 in regulating both
inflammation and repair. Various injuries stimulate a rapid and
dramatic induction of MMP7 production by the wounded
epithelium [3–11]. This expression is necessary for recruiting
inflammatory cells while promoting re-epithelialization [3–6]. Our
group previously reported MMP7 governs the inflammatory
response through the shedding of syndecan-1 [4]. Here, we
provide evidence that syndecan-1 shedding also serves to promote
re-epithelialization.
Damaged epithelium start spreading within minutes after injury
while the initiation of cell migration is delayed by several hours
[30,31]. Our data show that MMP7 regulates the migration
component of the re-epithelialization process. Migration is a
complex process that is affected by multiple interactions between
the cell and its environment [40]. In particular, cell-matrix
interaction must be tightly controlled to ensure affinity is adequate
for traction but not so excessive as to prevent forward migration
[38,39]. Therefore, MMP7 seems to be required for proteolysis of
a substrate that normally restrains cell migration. MMP7 is the
primary sheddase of syndecan-1 in the lungs after injury [4]. Our
findings demonstrate that MMP7 shedding of syndecan-1 also
facilitates wound closure. Indeed, syndecan-1 restricts migration as
demonstrated with the augmented wound closure in conditions
lacking syndecan-1. Moreover, lung epithelial cells transfected
with syndecan-1 resistant to MMP7 proteolysis attenuates cell
migration compared to wild-type syndecan-1. The Sdc1
2/2 and
Mmp7
2/2 conditions also have opposite repair phenotypes, and
Figure 6. Wounded Mmp7
2/2 lung epithelium has augmented wound closure with a2b1 integrin inhibition. Wild-type and Mmp7
2/2 ALI
cultures were injured in the presence of a control (hamster isotype IgG2;1 0mg/ml), a2 integrin subunit inhibiting antibody (clone Ha1/29; 10 mg/ml)
or a2b1 integrin inhibiting peptide (5 mM). The percent wound closure was determined 24 h after injury. *p,0.05, **p,0.01, ***p,0.001 by 2-way
ANOVA and Bonferroni analysis. n=4; Original magnification6100.
doi:10.1371/journal.pone.0006565.g006
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syndecan-1 releases restraints to cell migration.
Our data show that syndecan-1 augments cell adhesion to
collagen. This increase in cell-matrix binding, in turn, promotes
cell spreading but represses cell migration. Numerous studies have
documented a functional coupling of syndecan-1 with integrins
[34]. Our results describe how syndecan-1 indirectly governs cell-
matrix binding in the lungs by modulating a2b1 integrin affinity.
Syndecan-1 shedding could promote cell migration by re-
organizing cell interactions with the environment [25,40]. Indeed,
the loss of syndecan-1 has been shown to induce changes in the
cellular machinery that promote migration [18,19]. Integrin-
mediated attachments can also promote cell spreading [41], but
the cell may also require syndecan-1 as an additional signal to re-
organize the actin cytoskeleton and facilitate cell spreading [42–
49]. Certainly, changes in cell-matrix interaction can switch the
functional outcome of the cell [50,51]. Our findings indicate that
syndecan-1 regulates the affinity state of the a2b1 integrin subunit,
which in turn appears to coordinate cell attachments to the matrix
that are required for spreading and migration. This activation
event can occur quickly through a conformational change without
any need for protein expression as the required components are
already in place.
Syndecan-1 being functionally coupled to integrins has been
demonstrated in other models [34]. For example, syndecan-1
regulates the activation state of avb3 integrin potentially as a way for
breast carcinoma cells to acquire a more invasive phenotype [44,45].
Additionally, syndecan-1 associates with and facilitates the activation
of avb5 integrin in a fibroblast cell line [47]. Similarly, syndecan-1 was
found to directly interact with and modulate the affinity state of avb3
and avb5 integrins in endothelial cells to facilitate angiogenesis in vivo
[52]. Studies with keratinocytes show a migratory defect when
deficient in syndecan-1, possibly through alterations in laminin 332
binding integrins [17,53–55]. In contrast, Sdc1
2/2 dermal fibroblasts
have increased migration, increased b1 and av integrin subunit
expression and augmentation of av integrin subunit activity compared
to WT conditions [56]. Recently, syndecan-1 was found to physically
interact with the b1integrin subunit [57] and augment cell adhesion to
type I collagen by cooperating with a2b1 integrin [58]. Conversely,
other studies specifically evaluating syndecan-1 effects on the b1
integrin subunit found no difference in expression and activation
[19,43,46]. Syndecan-1 appears to have multiple possible interactions
with various integrins, depending on the cell system that is used. This
likely represents the fact that different lineages of cells express different
repertoires of surface and intracellular proteins from which syndecan-
1 can associate.
Figure 7. Wounded Sdc1
2/2 lung epithelium has attenuated repair with forced b1 integrin subunit activation. Wild-type and Sdc1
2/2
ALI cultures were injured in the presence of a control (rat isotype IgG, 1 mg/ml) or b1 integrin subunit activating (clone 9EG7, 1 mg/ml) or inhibiting
(clone AIIB2, 1 mg/ml) antibodies. The percent wound closure was determined 24 h after injury. *p,0.05 by 2-way ANOVA and Bonferroni analysis.
n=4; Original magnification6100.
doi:10.1371/journal.pone.0006565.g007
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Skin and corneal epithelium deficient in syndecan-1 have defective
re-epithelialization in vivo apparently due to attenuated prolifera-
tive and migratory responses [16,17,59]. Interestingly, syndecan-1
overexpression also inhibits skin repair in vivo possibly through
inhibitory actions from the syndecan-1 ectodomain [14]. One
explanation for the different effects of syndecan-1 is that the skin
and cornea have a stratified epithelium that is structurally and
functionally distinct from the simple epithelium in the lungs.
A recent study using A549 cells, a carcinoma-derived alveolar
type II cell line, reported that knockdown of syndecan-1
expression slowed cell migration [60]. The findings we present
here directly contradict the results in the A549 cell line. A549 cell
lines are cancerous in origin, and thus, changes associated with the
transformed phenotype may have altered the functions of
syndecan-1 and the pathways controlling cell movement, such as
that seen with breast cancer cells [44,45]. In contrast, we used a
non-cancerous cell line (BEAS-2b) and organotypic cultures
derived from primary epithelial cells, as well as in vivo models.
Further investigation would be needed to fully understand the
fundamental reasons for the different results found in these studies.
Together, our data support the conclusion that MMP7
facilitates re-epithelialization through the shedding of syndecan-
1, which then changes the activation state of the a2b1 integrin to
reduce cell affinity to collagen and remove restrictions to
migration. MMP7 is induced in the lungs by injury and sheds
syndecan-1 as a protective mechanism to recruit neutrophils while
promoting re-epithelialization. Because inflammation and repair
are two interrelated phenomena, MMP7 shedding of syndecan-1
could be the result of evolution co-opting two important biological
processes into one unified mechanism.
Materials and Methods
Ethics Statement
All animal procedures were approved by the Institutional
Animal Care and Use Committee at the University of Washington
and the National Institute of Health Guide for the Care and Use of
Laboratory animals.
Antibodies and Peptides
Clara cell specific protein (CCSP) was immunostained in mouse
tissue with a rabbit polyclonal antibody (Upstate, Lake Placid,
NY). Syndecan-1 antibodies were clone B-B4 for immunostaining
on human samples (BD Biosciences, San Jose, CA) and clone
281.2 for mouse tissue (kindly provided by P.W. Park; Children’s
Figure 8. Wounded Mmp7
2/2 lung epithelium has enhanced repair with b1 integrin subunit inhibition. Wild-type and Mmp7
2/2 ALI
cultures were injured in the presence of a control (rat isotype IgG, 10 mg/ml) or b1 integrin subunit activating (clone 9EG7, 10 mg/ml) or inhibiting
(clone AIIB2, 1 mg/ml) antibodies. The percent wound closure was determined 24 h after injury. *p,0.01, **p,0.001 by 2-way ANOVA and Bonferroni
analysis. n=4; Original magnification6100.
doi:10.1371/journal.pone.0006565.g008
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mation b1 integrin subunit was immunostained on human tissue
with clone 12G10 (Millipore, Billerica, MA) as previously
described [61]. All b1 integrin was immuostained with clone
AIIB2 (Developmental Studies Hybridoma Bank, Iowa City, IA;
Deposited by C. Damsky, UCSF). Appropriate Alexa Fluor
labeled secondary antibodies were from Invitrogen (Carlsbad,
CA).
Functional integrin activators and inhibitors were as follows.
Clone BHA2.1 was used as a functional a2b1 integrin inhibitor in
human cells [62,63]. The a2b1 ligand peptide (Anaspec, Fremont,
CA) inhibits integrin binding to collagen [64] and was used in
mouse cells. Clone Ha1/29 (BD Biosciences) was used as a mouse
a2 subunit inhibitor [65,66]. Clones HUTS-21 [67] and 9EG7
[68,69] were used respectively as human and mouse b1 subunit
activating antibodies. Clone AIIB2 was used to inhibit b1 subunit
function in both human and mouse systems [70]. Although the
clone AIIB2 antibody was generated toward the human b1
subunit, cross-reactivity with several species have been established
[71–73], and preliminary studies showed effect in blocking
adhesion of murine cells (data not shown). All functional
experiments were matched with isotype antibody controls from
Santa Cruz Biotechnologies (general rat isotype), BD Biosciences
(Armenian Hamster IgG2) and BioLegend (all mouse and rat
monoclonal isotype controls). The one exception is when 9EG7
(rat IgG2a) and AIIB2 (rat IgG1) were both used (Figures 7 and 8),
a general rat isotype IgG antibody (Santa Cruz Biotechnologies)
was used as a common control. Preliminary experiments showed
no difference between rat monoclonal IgG isotypes and the
general rat IgG control (data not shown).
Lung injury models
Air-liquid interface (ALI) cultures were created from wild-type
(WT), MMP7-null (Mmp7
2/2) and syndecan-1-null (Sdc1
2/2)
mice all on a C57BL/6 background, and wound closure assays
were performed as previously described [6]. Additionally, time-
lapse microscopy of the repairing ALI culture obtained DIC
images every 6 min over 24 h on a DeltaVision Olympus IX71
inverted microscope using a 20x/0.75 U plan Apo objective and a
Photometric Coolsnap HQ camera (Applied Precision, Issaquah,
WA).
The naphthalene injury model was used to study repair in vivo
[6]. WT, Mmp7
2/2 and Sdc1
2/2 mice had intraperitoneal
injections of 200 mg/kg sterile naphthalene dissolved in corn oil.
All mice were injected between 8–10 am to minimize diurnal
variations in naphthalene metabolism. Mice were sacrificed at the
defined time point, bronchoalveolar lavage fluid was collected and
the lung tissue was processed for histology.
Knockdown and Overexpression Cell Lines
The pSM2 vector containing shRNA specific for the human
syndecan-1 gene or the luciferase gene was purchased from Open
Biosystems (Huntsville, AL). Wild-type human MMP7 was
mutated to contain a furin cleavage site at the junction of the
pro- and catalytic domain (generously provided to us by D.
Madtes; Fred Hutchinson Cancer Research Center, Seattle, WA).
This construct was subcloned using BamHI and NotI restriction
sites into the pBM-IRES-blastocidin retroviral expression plasmid
(kindly provide by E. Raines; University of Washington, Seattle,
WA). The full-length WT mouse syndecan-1 (mSdc1) was also
PCR cloned from cDNA created from whole lung RNA, and the
PCR product was inserted into the GFP Fusion TOPO TA
expression kit (Invitrogen, Carlesbad, CA). A non-cleavable
syndecan-1 (NC-mSdc1) was created by replacing the juxtamem-
brane MMP cleavage site with 15 amino acids from the human
CD4 juxtamembrane sequence as previously described [25–27].
Stable knockdown cells were created using a retroviral
transduction system. For both shRNA and overexpressing
retroviral expression systems, retroviral particles were produced
by transiently transfecting plasmid DNA into the PhiNx
amphoteric packaging cell line (ATCC, Manassas, VA; Deposited
by G. Nolan) [74]. Target cells were infected with retroviral
conditioned medium containing 10 mg/ml DEAE-Dextran for
16 h at 33uC before being transferred to 37uC in fresh medium
[75]. Two days after infection, medium containing the appropriate
selection antibiotic was added and stably transduced cell lines were
selected. Additionally, cells were transiently transfected to express
mSdc1 or NC-mSdc1 with Lipofectamine 2000 (Invitrogen)
following manufacturer’s directions.
Histology and Immunostaining
All immunostaining of ALI cultures and of cell lines were
performed on 100% methanol-fixed cultures. H&E staining and
CCSP immunofluorescent staining was performed on 10%
formalin-fixed, paraffin-embedded naphthalene injured tissue
sections as previously described [6]. Epifluorescence images were
captured using an Olympus BX-51 fluorescence/DIC microscope
with U plan Apo 40x/0.85 and 20x/0.70 objectives and an
Olympus DP25 5.5 megapixel digital camera. All immunofluo-
rescent slides were processed with identical conditions. Images
were captured with equal exposures and microscope settings.
When necessary, minor linear changes to intensity were made
equally with ImageJ software.
Migration, Spreading and Adhesion Assays
Assays to evaluate cell-matrix interactions effects on compo-
nents of repair were employed. Cell spreading was evaluated as
previously described [6]. Plated cells were allowed to spread for
60 min on various matrices, and the percent of cells spread
compared to all plated cells was determined. We also evaluated
cell migration using a modified colloid gold migration assay [33].
The protocol was modified so that experiments were performed on
Permanox chamber slides (Nunc, Rochester, NY). In each
experiment of the migration assay, at least 10 cells were randomly
chosen, and the migration area was measured with ImageJ
software. Scratch wound assays were also used as a method to
measure migration and wound closure [5,6].
Cell adhesion to a matrix was determined with a modified cell
adhesion assay [76]. Cells were pre-labeled with 5 mM calcein AM
(Alexis Biochemicals, San Diego, CA) in 10% FBS DMEM
medium for 30 min. Cells were then washed and lifted from the
culture plate by incubating in PBS-EDTA at 37uC for 10 min. All
cells were collected and washed with PBS before plating onto
matrix coated 96-well round-bottom plates in 1% FBS phenol-free
DMEM (10,000 cells per well in 100 ml total volume). To
synchronize the initial cell-matrix contact, plates were centrifuged
at 306g for 3 min. Total fluorescence (excitation 485, emission
530) was measured at 0 h as a baseline. After 30 min at 37uC,
plates were washed with an electronic multichannel pipettor set at
a consistent ejection force for all experiments to remove non-
adherent cells. After three washes of PBS, 100 ml of 1% FBS
phenol-free DMEM was replaced into each well and the overall
fluorescence was measured. The percent adherence was deter-
mined by a ratio of the fluorescent signal at 30 min compared to
baseline. When indicated, cell adhesion assays were performed in
the presence of isotype and functional activating and inhibiting
antibodies. To compare among different experiments, which may
require different control antibodies, all data was normalized to the
MMP7 Sheds Syndecan-1
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Supporting Information
Video S1 Wound closure of wild-type and MMP72/2 ALI
cultures. Wild-type and MMP72/2 ALI cultures were injured
and wound closure was observed over 24 hours.
Found at: doi:10.1371/journal.pone.0006565.s001 (21.22 MB
MOV)
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